Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes.

Shen L, Kantarjian H, Guo Y, Lin E, Shan J, Huang X, Berry D, Ahmed S, Zhu W, Pierce S, Kondo Y, Oki Y, Jelinek J, Saba H, Estey E, Issa JP.

J Clin Oncol. 2010 Feb 1;28(4):605-13. doi: 10.1200/JCO.2009.23.4781. Epub 2009 Dec 28. Erratum in: J Clin Oncol. 2010 Jun 20;28(18):3098.

PMID:
20038729
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.

Lin J, Wang YL, Qian J, Yao DM, Zhu ZH, Qian Z, Xu WR.

Leuk Res. 2010 Aug;34(8):991-4. doi: 10.1016/j.leukres.2010.01.003. Epub 2010 Jan 29.

PMID:
20116099
[PubMed - indexed for MEDLINE]
3.

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.

Wang H, Wang XQ, Xu XP, Lin GW.

Leuk Res. 2010 May;34(5):598-604. doi: 10.1016/j.leukres.2009.09.031. Epub 2009 Oct 23.

PMID:
19853913
[PubMed - indexed for MEDLINE]
4.

Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.

Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P.

Eur J Haematol. 2006 Jan;76(1):23-32.

PMID:
16343268
[PubMed - indexed for MEDLINE]
5.

Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.

Beran M.

Int J Hematol. 2000 Aug;72(2):139-50. Review.

PMID:
11039661
[PubMed - indexed for MEDLINE]
6.

Outcome of patients with myelodysplastic syndromes: experience from a single institution in South Australia.

Hui CH, Horvath N, Lewis I, To LB, Szabo F.

Intern Med J. 2008 Nov;38(11):824-8. doi: 10.1111/j.1445-5994.2007.01582.x. Epub 2008 Feb 15.

PMID:
18284457
[PubMed - indexed for MEDLINE]
7.

Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.

Poloni A, Goteri G, Zizzi A, Serrani F, Trappolini S, Costantini B, Mariani M, Olivieri A, Catarini M, Centurioni R, Alesiani F, Giantomassi F, Stramazzotti D, Biagetti S, Alfonsi S, Berardinelli E, Leoni P.

Eur J Haematol. 2013 Sep;91(3):219-27. doi: 10.1111/ejh.12145. Epub 2013 Jun 28.

PMID:
23679560
[PubMed - indexed for MEDLINE]
8.

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ.

Hematol J. 2002;3(3):137-44.

PMID:
12111649
[PubMed - indexed for MEDLINE]
9.

The lower risk MDS patient at risk of rapid progression.

Mittelman M, Oster HS, Hoffman M, Neumann D.

Leuk Res. 2010 Dec;34(12):1551-5. doi: 10.1016/j.leukres.2010.05.023. Epub 2010 Jun 22. Review.

PMID:
20573398
[PubMed - indexed for MEDLINE]
10.

p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.

Kim M, Oh B, Kim SY, Park HK, Hwang SM, Kim TY, She CJ, Yang I, Yoon SS, Yoon JH, Lee DS.

Leuk Res. 2010 Jun;34(6):718-22. doi: 10.1016/j.leukres.2009.09.007. Epub 2009 Sep 25.

PMID:
19782398
[PubMed - indexed for MEDLINE]
11.

Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.

Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, Shay JW, Ohyashiki K.

Clin Cancer Res. 1999 May;5(5):1155-60.

PMID:
10353751
[PubMed - indexed for MEDLINE]
Free Article
12.

DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.

Leone G, Teofili L, Voso MT, L├╝bbert M.

Haematologica. 2002 Dec;87(12):1324-41. Review.

PMID:
12495905
[PubMed - indexed for MEDLINE]
Free Article
13.

Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.

Lin J, Yao DM, Qian J, Wang YL, Han LX, Jiang YW, Fei X, Cen JN, Chen ZX.

Leuk Res. 2008 Oct;32(10):1541-5. doi: 10.1016/j.leukres.2008.02.008. Epub 2008 Mar 25.

PMID:
18367246
[PubMed - indexed for MEDLINE]
14.

Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes.

Wang H, Wang X, Xu X, Lin G.

Ann Hematol. 2010 Jul;89(7):671-9. doi: 10.1007/s00277-010-0912-6. Epub 2010 Feb 24.

PMID:
20179929
[PubMed - indexed for MEDLINE]
15.

Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes.

Dhodapkar M, Grill J, Lust JA.

Leuk Res. 1995 Oct;19(10):719-26.

PMID:
7500648
[PubMed - indexed for MEDLINE]
16.

Improvement of the WHO classification-based prognostic scoring system (WPSS) by including age for Korean patients with the myelodysplastic syndrome.

Kim SH, Lee JH, Choi J, Kwon KA, Lee S, Oh SY, Kwon HC, Han JY, Kim HJ.

Leuk Res. 2010 Dec;34(12):1589-95. doi: 10.1016/j.leukres.2010.03.003. Epub 2010 Jul 14.

PMID:
20633929
[PubMed - indexed for MEDLINE]
17.

Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.

Verburgh E, Achten R, Maes B, Hagemeijer A, Boogaerts M, De Wolf-Peeters C, Verhoef G.

J Clin Oncol. 2003 Jan 15;21(2):273-82.

PMID:
12525519
[PubMed - indexed for MEDLINE]
18.

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP.

Blood. 2009 Feb 5;113(6):1315-25. doi: 10.1182/blood-2008-06-163246. Epub 2008 Oct 2.

PMID:
18832655
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study.

Wang H, Wang X, Xu X, Lin G.

Ann Hematol. 2010 Jun;89(6):535-44. doi: 10.1007/s00277-009-0861-0. Epub 2009 Nov 17.

PMID:
19921190
[PubMed - indexed for MEDLINE]
20.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.

Lee JH, Lee JH, Lim SN, Kim DY, Kim SH, Lee YS, Kang YA, Kang SI, Jeon MJ, Seol M, Seo EJ, Chi HS, Park CJ, Jang S, Yun SC, Lee KH.

Bone Marrow Transplant. 2010 Mar;45(3):450-7. doi: 10.1038/bmt.2009.190. Epub 2009 Aug 10.

PMID:
19668236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk